TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?
Presenter:
We Recommend
Disclosures
Nothing to disclose
Advertisement
Sign In
New at TCTMD? Register today!
Forgot Your Password?
Enter the email you used to register to reset your password.
Search TCTMD
cme